[Ca2+/calmodulin-dependent protein kinase II--a target for sodium valproate?].
Savina
T A
TA
Balashova
O A
OA
Shchipakina
T G
TG
D000161:Acoustic Stimulation; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000378:metabolism*; D004789:Enzyme Activation; D006624:Hippocampus / Q000201:enzymology; D007245:Inferior Colliculi / Q000201:enzymology; D008297:Male; D019579:Neocortex / Q000201:enzymology; D051381:Rats; D012640:Seizures / Q000188:drug therapy* / Q000201:enzymology; D014635:Valproic Acid / Q000494:pharmacology*
D000927:Anticonvulsants; D014635:Valproic Acid; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2; D017871:Calcium-Calmodulin-Dependent Protein Kinases